Enanta Pharmaceuticals reported $1.42M in Loan Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Amgen AMGN:US USD 37.16B 1.46B
AstraZeneca AZN:LN USD 23.68B 3.47B
Biogen BIIB:US USD 6.28B 1.8M
Bristol Myers Squibb BMY:US USD 36.97B 141M
Enanta Pharmaceuticals ENTA:US USD 1.42M 83K
GlaxoSmithKline GSK:LN GBP 19.32B 538M
Halozyme Therapeutics HALO:US USD 1.49B 344.03M
Insmed INSM:US USD 807.48M 366K
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
IONIS PHARMACEUT IONS:US USD 1.25B 1.1M
Karyopharm Therapeutics KPTI:US USD 302.89M 201K
Marinus Pharmaceuticals MRNS:US USD 70.78M 430K
Novartis NOVN:VX USD 21.24B 2.55B
Ptc Therapeutics PTCT:US USD 981.61M 165K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M
YTE INCY:US USD 30.48M 681K